Showing results (1-10 of 309) with videos related to
Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|July 23, 2019
Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder CancerMadhuri Koti, Amanda Shuo Xu, Kevin Yi Mi Ren, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2016
Alvimopan in an Enhanced Recovery Program Following Radical CystectomyZach Hamilton, Will Parker, Josh Griffin, et al.Bladder Cancer (Amsterdam, Netherlands)|June 16, 2025
The importance of maximal TURBT in trimodality therapy for muscle-invasive bladder cancer (MIBC)Chris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.Bladder Cancer (Amsterdam, Netherlands)|March 20, 2025
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette-Guérin therapy in patients with non-muscle invasive bladder cancerMakito Miyake, Kota Iida, Nobutaka Nishimura, et al.Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder CancerGeorge W Moran, Gen Li, Dennis J Robins, et al.Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
High-throughput DNA Sequencing Identifies Novel CtIP (RBBP8) Variants in Muscle-invasive Bladder Cancer PatientsSarah J Jevons, Angela Green, Gerton Lunter, et al.Bladder Cancer (Amsterdam, Netherlands)|December 24, 2019
PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysisWei Phin Tan, Wei Shen Tan, Brant A InmanBladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive DiseaseRyan L Steinberg, Lewis J Thomas, Michael A O'DonnellBladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Treatment Decision Making in Patients with Bladder CancerDonna L Berry, Manan Nayak, Barbara Halpenny, et al.Pageof 31